PSAP 前列腺酸性磷酸酶

廣州健侖生物科技有限公司

PsAP（Prostatic specific Acid Phosphatase）是由前列腺上皮細(xì)胞分泌的一種酸性磷酸酶的同工酶，在正常前列腺、增生的前列腺組織和前列腺癌中均表達(dá)PSAP。此抗體主要用于前列腺癌和轉(zhuǎn)移性前列腺癌的研究，但不能作為良、惡性前列腺疾病的研究。

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢

PSAP 前列腺酸性磷酸酶

【產(chǎn)品介紹】

細(xì)胞定位：細(xì)胞漿

克隆號：EP-PR8

同型:IgG

適用組織：石蠟/冰凍

陽性對照：前列腺/前列腺癌

抗原修復(fù)：熱修復(fù)（EDTA）

抗體孵育時(shí)間：60min

PSAP

想了解更多的產(chǎn)品及服務(wù)請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】     歐

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號二期2幢101-103室

2型糖尿病患者機(jī)體的血糖提供了一定的幫助，同時(shí)也揭示了，刺激mTORC2信號通路從而利用棕色脂肪燃燒的能量或許是治療肥胖的有效策略。
近日，一項(xiàng)發(fā)表于雜志Circulation上的研究論文中，來自休斯頓衛(wèi)理公會研究所的研究人員成功地將人類機(jī)體的抗原抗體細(xì)胞轉(zhuǎn)化成為血管細(xì)胞，該研究發(fā)現(xiàn)或?yàn)殚_發(fā)修復(fù)損傷組織的療法以及改善機(jī)體組織供血、氧氣、營養(yǎng)的新方法提供了一定的幫助和希望。
John Cooke教授表示，據(jù)我們所知，本文研究是*利用小分子和蛋白來完成治療細(xì)胞類型的分化轉(zhuǎn)移，在特殊情況下我們就可以將成纖維細(xì)胞轉(zhuǎn)化成為所需的細(xì)胞類型。文章中研究者首先將成纖維細(xì)胞暴露于多聚胞苷酸(polyinosinic-polycytidylic acid，poly I：C)中，雙鏈RNA分子的一小部分會結(jié)合宿主細(xì)胞的TLR3(toll樣受體3)來“哄騙”細(xì)胞好像針對病毒攻擊那樣產(chǎn)生反應(yīng);在2012年發(fā)表在Cell上的一篇研究文章中，Cooke教授就揭示了成纖維細(xì)胞對病毒攻擊的反應(yīng)，在利用poly I：C處理成纖維細(xì)胞后，研究者觀察到了細(xì)胞核染色質(zhì)的重新組裝，這種組裝可以使得之前關(guān)閉的基因重新表達(dá)，隨后利用諸如VEGF等因子對成纖維細(xì)胞進(jìn)行處理，就可以將少量分化的細(xì)胞轉(zhuǎn)化成為內(nèi)皮細(xì)胞。

Blood glucose in patients with type 2 diabetes may provide some help, but it also reveals that stimulating the mTORC2 signaling pathway to harness the energy of brown fat may be an effective strategy for treating obesity.
Recently, in a research paper published in the journal Circulation, researchers from the Methodist Institute in Houston successfully transformed the antigen-antibody cells of human bodies into vascular cells. The study found or was developed for the treatment of damaged tissues As well as to improve the body tissue for blood, oxygen, nutrition, new methods provide some help and hope.
According to Professor John Cooke, as far as we know, this study is the first to utilize small molecules and proteins to complete the differentiation and metastasis of treated cell types. Under special circumstances, we can transform fibroblasts into desired cell types. In the article, researchers first exposed fibroblasts to polyinosinic-polycytidylic acid (poly I: C), and a small portion of the double-stranded RNA molecule binds to the host cell's TLR3 (toll-like receptor 3) "Kidding" cells seem to react as they did to virus attacks; in a research article published in the Cell in 2012, Professor Cooke revealed the fibroblast response to viral challenge by treating fibroblasts with poly I: C After the researchers observed a reassembly of the chromatin in the nucleus, this assembly allows the previously closed gene to be re-expressed, followed by treatment of fibroblasts with factors such as VEGF, which can transform small numbers of differentiated cells into endothelial cells.